Enhertu Sharply Improves Survival In Breast Cancer Patients: ReportA drug from AstraZeneca Plc and Daiichi Sankyo Co. extended the lives of patients with an advanced form of breast cancer by about six months in a late-stage trial that may widen the population of...
